markets

vVardis Secures $175 Million Funding Ahead of NYSE Debut

Summarized from Economic News, Trends, Analysis

Swiss oral-care startup vVardis has raised $175 million in pre-IPO funding as it prepares to list on the New York Stock Exchange.

vVardis Secures $175 Million Funding Ahead of NYSE Debut

Swiss luxury oral-care company vVardis has closed a $175 million funding round ahead of a planned initial public offering on the New York Stock Exchange, according to a pre-market advisory issued directly from the NYSE trading floor on Nov. 13, 2026.

The capital raise signals strong investor appetite for the brand ahead of its public market debut. vVardis, known for its premium dental-care products, is positioning the IPO as a next step in scaling its consumer health business on a global stage.

Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →

The NYSE issues daily pre-market updates from its trading floor, flagging notable listings, funding events, and market developments for investors preparing for the opening bell. The vVardis announcement was highlighted as a key pre-market item of interest on that date.

While specific terms of the funding round — including lead investors or the anticipated IPO valuation — were not detailed in the advisory, the $175 million figure underscores substantial institutional confidence in the company ahead of what would be a high-profile consumer health listing in New York.

Continue reading at Economic News, Trends, Analysis.

Frequently Asked Questions

Q.How much did vVardis raise before its NYSE IPO?

vVardis raised $175 million in a pre-IPO funding round ahead of its planned listing on the New York Stock Exchange.

Q.What exchange is vVardis planning to list on?

vVardis is preparing to debut on the New York Stock Exchange (NYSE).

Q.When was the vVardis funding announcement made?

The funding raise was highlighted in an NYSE pre-market advisory issued on November 13, 2026.

More in markets →